Abstract
Hepatitis B vaccines are not generic products and it cannot be assumed that all such vaccines can be used in reduced doses in order to save costs. Any use of vaccines in an unlicensed manner should only be performed in the context of a study that is approved by the national control authority and appropriate ethical review committees.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Goh K. T., Oon C. J., Heng B. H., Lim G. K. Long-term immunogenicity and efficacy of a reduced dose of plasma-based hepatitis B vaccine in young adults. Bull World Health Organ. 1995;73(4):523–527. [PMC free article] [PubMed] [Google Scholar]